Literature DB >> 4394527

Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the rat.

M Henning, A Rubenson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4394527     DOI: 10.1111/j.2042-7158.1970.tb10570.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  20 in total

1.  Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L-DOPA in the rat.

Authors:  J P M Finberg; A Gross; O Bar-Am; R Friedman; Y Loboda; M B H Youdim
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

2.  Selective inhibition of monoamine oxidase type B by MDL 72145 increases the central effects of L-dopa without modifying its cardiovascular effects.

Authors:  J R Fozard; M G Palfreyman; M Robin; M Zreika
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

3.  Missing indicator function of growth hormone and luteinizing hormone blood levels for dopamine and serotonin concentration in the human brain.

Authors:  O Benkert; G Laakmann; A Souvatzoglou; K von Werder
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

4.  Action of thymoxamine on mydriasis induced by levodopa and dopamine.

Authors:  A S Spiers; D B Calne; S D Vakil; T M French
Journal:  Br Med J       Date:  1971-05-22

5.  Cardiovascular effects of 6-hydroxydopamine injected into a lateral brain ventricle of the rat.

Authors:  G Haeusler; M Gerold; H Thoenen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

6.  Mode of action of L-DOPA on central noradrenaline mechanisms.

Authors:  N E Andén; J Engel; A Rubenson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

7.  Central decarboxylation and uptake of L-DOPA.

Authors:  N E Andén; J Engel; A Rubenson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

8.  The cardiovascular effects of L-dopa in the pithed rat.

Authors:  E Eden; P A Nasmyth
Journal:  Br J Pharmacol       Date:  1974-08       Impact factor: 8.739

9.  The use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy-Drager syndrome).

Authors:  A J Lees; R Bannister
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-04       Impact factor: 10.154

10.  Levodopa therapy for Parkinsonism in the Shy-Drager syndrome.

Authors:  M J Aminoff; C S Wilcox; M M Woakes; M Kremer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.